Redian新闻
>
Reminder: CLSPA Career Symposium early bird registration ends today, register now
avatar
Reminder: CLSPA Career Symposium early bird registration ends today, register now# ChemEng - 化学工程
w*z
1
Reminder: $5 early bird registration for CLSPA Career Symposium 2010 ends
today, register now at the discount if you plan to attend.
Registration at http://www.acteva.com/booking.cfm?bevaid=210931
CLSPA Career Symposium 2010
October 30th, Saturday
Room 401, Hammer Building, Columbia University Medical Center.
Speakers and Agenda:

12:30 - 1:30 pm Registration and mingling
1:30 - 2:00 pm Opening remarks: Wangzhi Li, Founding President of CLSPA
2:00 - 3:15 pm 1st Session: research-based careers in life sciences field
I. Panel discussion (25 minutes)
Panelists: Yi Zhong , Professor at Cold Spring Harbor Laboratory in USA
and Tsinghua University in China

Ergang Shi, Sr. scientist and HTS group associate director at Regeneron
Zhi Chen, Sr. scientist at Novartis
II. A following attendee case review (10 minutes) and Q & A with the
audience (40 minutes)
3:15-3:45 pm Coffee break & networking
3:45-5:15 pm 2nd Session: alternative careers with life sciences background
I. Panel Discussion (40 minutes)
Panelists: Suhua Zhang , Sr. director at Bristol Myer Squipp
Ting Jia, Associate at Mckinsey
Eric Vieira, Assistant director at Office of Technology & Business
Development of the Mount Sinai Medical Center and former Wall Street senior
biotech equity analyst
Jahan Ali, Sr. vice president of New York City Investment Fund
Larry Wang, co-founder and president of GenScript
Jean Qiu, Founder and CTO of Nexcelom Bioscience
II. A following attendee case review (10 minutes) and Q & A with the
audience (60 minutes)
5:20 - 5:25 pm Closing remarks
5:25 - 5:30 pm Evaluation form collection
5:30 - 5:35 pm Lottery to select the Lucky Audience of the Symposium and
Award
6:30 - 9:00 pm Private dinner (optional)
12:30 -5:40 pm Sponsor exhibits
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。